Holen Sie sich die Stockscreener-App
84.46
0.28%
0.2364
Schlusskurs vom Vortag:
$84.22
Offen:
$84.48
24-Stunden-Volumen:
808
Relative Volume:
0.14
Marktkapitalisierung:
$281.93M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+2.57%
1M Leistung:
+6.03%
6M Leistung:
+26.62%
1J Leistung:
+22.54%
1-Tages-Spanne:
$84.39
$84.48
1-Wochen-Bereich:
$81.33
$85.73
52-Wochen-Spanne:
$54.52
$85.73
Invesco Biotechnology Genome Etf Stock (PBE) Company Profile
Firmenname
Invesco Biotechnology Genome Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie PBE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBE
Invesco Biotechnology Genome Etf
|
84.39 | 281.93M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
340.94 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
691.09 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
694.15 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
270.21 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
622.14 | 124.43B | 0 | 0 | 0 | 0.00 |
Invesco Biotechnology Genome Etf Aktie (PBE) Neueste Nachrichten
Genome ETF stock stage a strong rebound this quarterEarnings Growth Summary & Weekly Market Pulse Alerts - ulpravda.ru
Invesco Biotechnology & Genome ETF (NY: PBE - FinancialContent
PRN_FinancialWrapper | PR NewswireInvesco Biotechnology & Genome ETF (NYSE:PBE) Detailed Stock Data - FinancialContent
Invesco Exchange-Traded Fund TrustInvesco Biotechnology & Genome ETF Reports Earnings Results for the Half Year Ended October 31, 2025 - MarketScreener
Institution Moves: Can Invesco Biotechnology Genome ETF stock sustain breakout momentumShare Buyback & Fast Gain Swing Trade Alerts - moha.gov.vn
Genome ETF stock among top earnings playsQuarterly Earnings Report & Proven Capital Preservation Tips - Улправда
Genome ETF stock deliver double digit returnsQuarterly Portfolio Report & AI Based Trade Execution Alerts - Улправда
Is Invesco Biotechnology & Genome ETF (PBE) a Strong ETF Right Now? - sharewise.com
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - MSN
Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance - Business Wire
Inside the Recent Strength in Biotech ETFs - TradingView
Genome ETF stock announce special dividendWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - newser.com
Genome ETF stock considered safe havenJuly 2025 Setups & Stepwise Trade Signal Implementation - newser.com
2 ETFs to Watch for Outsized Volume on Biotechnology Stocks - TradingView
5 Best ETFs Tracking CRISPR Gene Editing - The Motley Fool
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.2341 - MSN
Genome ETF stock compared to rivalsJuly 2025 News Drivers & Precise Swing Trade Alerts - Trung tâm Dự báo KTTV quốc gia
Genome ETF stockChart Signals & Fast Exit and Entry Trade Guides - newser.com
Wealth Enhancement Advisory Services LLC Sells 2,491 Shares of Invesco Biotechnology & Genome ETF $PBE - Defense World
Genome ETF stock benefit from mergersTrade Risk Summary & Consistent Return Strategy Ideas - newser.com
The Best Biotech ETFs to Buy - Kiplinger
Genome ETF stock deliver strong annual returnsJuly 2025 Drop Watch & Weekly Watchlist for Consistent Profits - newser.com
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk - Benzinga
Signet Financial Management LLC Grows Position in Invesco Biotechnology & Genome ETF $PBE - Defense World
Invesco Biotechnology & Genome ETF $PBE Position Decreased by HighTower Advisors LLC - Defense World
7 Best Biotech ETFs to Buy Now - US News Money
Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) Shares Sold by LPL Financial LLC - Defense World
Cetera Investment Advisers Has $1.34 Million Holdings in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) - Defense World
Global X Genomics & Biotechnology ETF (NASDAQ:GNOM) Shares Acquired by Private Advisor Group LLC - Defense World
Invesco (IVZ) Rallies 0.18% to Highest Since July 2025 Amid Asset Management Sector Reassessment - AInvest
PBE ETF: A Comprehensive Guide to Its Fundamentals and Performance - AInvest
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)? - Yahoo Finance
Invesco Nasdaq Biotechnology ETF IBBQ 2025Q2 Earnings Preview Upside Potential on Biotech Sector Growth - AInvest
Finanzdaten der Invesco Biotechnology Genome Etf-Aktie (PBE)
Es liegen keine Finanzdaten für Invesco Biotechnology Genome Etf (PBE) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):